Mankind Pharma Limited (NSE: MANKIND)

Market Cap	1.05T
Revenue (ttm)	116.41B
Net Income (ttm)	20.41B
Shares Out	412.57M
EPS (ttm)	50.81
PE Ratio	50.29
Forward PE	47.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	449,091
Average Volume	645,069
Open	2,445.00
Previous Close	2,481.60
Day's Range	2,434.80 - 2,595.00
52-Week Range	1,901.05 - 3,054.80
Beta	n/a
RSI	46.81
Earnings Date	Feb 4, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 19,540
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANKIND

Financial Performance

In 2023, Mankind Pharma's revenue was 103.35 billion, an increase of 18.12% compared to the previous year's 87.49 billion. Earnings were 19.13 billion, an increase of 49.23%.